ArticleMaedica2026
Cytological and Immunohistochemical Analysis of Human Fetal Brain across Different Gestational Ages.
Article in Maedica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Human fetal brain development involves complex processes of cellular proliferation, neuronal migration and differentiation. Although several studies have independently evaluated cytology or immunohistochemistry in fetal brain development, integrated analyses using both approaches remain limited. Methods: This descriptive observational study was conducted on brain tissues obtained from nine aborted human fetuses of different gestational ages distributed across the first, second and third trimesters. Fetuses with visible congenital anomalies, autolysis, or damaged brain tissue were excluded. Histological evaluation was performed using Masson's trichrome and reticulin stains. Immunohistochemical analysis was carried out using Ki-67, c-myc and Ber-H2 (CD30) antibodies. Immunostaining intensity was graded semi-quantitatively on a scale from 0 to 4+ according to the percentage of immunoreactive cells. Results: Developing neuronal cells and pyramidal neurons were observed predominantly in later gestational stages, along with scattered oligodendrocytes and reticular fibers. Immunopositive cells were mainly localized in the white matter and ventricular regions, whereas comparatively lower staining was observed in the granular layers. Progressive increases in immunoreactivity were observed with advancing gestational age, particularly in the ventricular zone, cortical plate and white matter. Among the markers studied, Ki-67 demonstrated the highest immunopositivity, followed by c-myc and Ber-H2 (CD30). Conclusion: The present study demonstrates gestation-related variations in the immunohistochemical expression of Ki-67, c-myc and Ber-H2 (CD30) in the developing human fetal brain. These findings contribute baseline developmental data that may assist future studies investigating fetal neurodevelopment and neuropathological conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.